Metacarpal secures £800,000 to accelerate launch of fully mechanical prosthetic hand

Scottish medtech spin-out to scale manufacturing, double headcount and tackle low prosthetic adoption worldwide

Edinburgh, Scotland, UK (August 27, 2024) – Metacarpal, the Edinburgh-based medtech company developing a new class of fully mechanical prosthetic hands, today announced it has secured £800,000 in funding to advance its first product into manufacturing and early commercial rollout. The investment will enable the company to expand its team, scale production and deepen clinical collaborations as it works to improve everyday function and quality of life for people with upper-limb difference.

The funding round brings together a syndicate of impact-driven and innovation-focused investors, including SIS Ventures, Scottish Enterprise, Worth Capital, Oxford Technology, the University of Strathclyde and the Gabriel Investment Syndicate. Their backing will support Metacarpal as it finalises its commercial design, establishes its first manufacturing capability and grows its headcount to build the engineering and operational capacity required for launch.

Metacarpal is developing what is believed to be the first fully mechanical prosthetic hand to deliver advanced, multi-grip functionality without any onboard electronics. Powered and controlled entirely by the user’s own body movement, the device uses a novel mechanical architecture to provide refined control, functional grips and robust, real-world performance in a solution designed to be intuitive to learn and simple to maintain.

The company is targeting a long-standing challenge in upper-limb prosthetics: many users either abandon their devices or choose not to adopt a prosthesis at all, often due to issues with complexity, fragility, weight or limited functional benefit. By focusing on a purely mechanical system that aims to combine practicality with higher-level function, Metacarpal seeks to increase long‑term device use and help reduce the physical and social impact of limb loss for a wider range of users.

Metacarpal was founded by product design engineering graduate Fergal Mackie, whose own experience of serious wrist injuries during his studies highlighted the critical role of hand function in daily life and sparked a drive to rethink how prosthetic hands are designed. Under his leadership, Metacarpal has evolved from an early-stage concept into a venture-backed spin‑out with a clear mission to raise the standard of upper-limb prosthetics through disruptive mechanical engineering.

With the new funding in place, Metacarpal will focus on completing product development, initiating pilot manufacturing runs and working with clinical and prosthetic partners on real‑world evaluations ahead of wider market entry. The company will also continue to invest in its underlying technology platform, laying the foundations for a family of upper-limb solutions tailored to different user needs, activities and healthcare settings.

Share it on:

More insights